T-cell engagers to drive immuno-oncology next growth wave: GlobalData EP News Bureau Aug 12, 2025 Bispecific T-cell engagers forecast to expand from 10% to 35% of the global immuno-oncology market by 2031 as immune checkpoint…
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData EP News Bureau Sep 29, 2020 There are106 bispecific antibody molecules in the pipeline and 263 ongoing/planning to enrol clinical trials involving a…
